A$5.0 million commitment received from Australian-based private investor A$10.8 million Entitlement Offer at the same offer price as the placement Funds to support Phase III Topical clinical trials in ...
Hosted on MSN
Recce Pharmaceuticals secures A$85 million R&D tax incentive for global anti-infective programs
Recce Pharmaceuticals Ltd. ( (AU:RCE)) has shared an update. Recce Pharmaceuticals has been awarded an Advanced Overseas Finding for up to A$85 million by the Australian Government, which extends the ...
Recce Pharmaceuticals Ltd. (AU:RCE) has released an update. Recce Pharmaceuticals Ltd. is nearing the completion of its Phase II clinical trial for RECCE 327 Topical Gel, a synthetic anti-infective ...
Recce Pharmaceuticals Ltd. (AU:RCE) has released an update. Recce Pharmaceuticals Ltd has announced its participation in the 2024 Military Health System Research Symposium, where it will present ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results